ArticleScientific reports2022
Prevalence, awareness, treatment, and control of hypertension based on ACC/AHA versus JNC7 guidelines in the PERSIAN cohort study.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Prehypertension and hypertension among older adults: prevalence, awareness, treatment, control and associated factors - findings from Iranian STEPS survey (2016 and 2021).Aging clinical and experimental research · 2026Article
- QALY losses for non-communicable diseases in Iranian adults: insights from a national cross-sectional study.Population health metrics · 2026Article
- Hypertension Control in Bangladesh: Changes, Sociodemographic Variation, and Socioeconomic Inequality from the 2017-18 to 2022 Bangladesh Demographic and Health Surveys.Global heart · 2026Article
- Awareness, Treatment, and Control of Hypertension Among Hypertensive Older Adults in Iran: A Cross-Sectional Study From the Ardakan Cohort Study on Aging.Health science reports · 2025Article
- Burden of High Systolic Blood Pressure in the Eastern Mediterranean Region, 1990 to 2021: Results From the Global Burden of Disease Study 2021.Journal of the American Heart Association · 2025Article
- Implications of the dissemination of healthy lifestyle advice for Afghan adults without histories of hypertension diagnosis or treatment.Journal of rural medicine : JRM · 2025Article
- Cardiometabolic risk factors trend in Iranian adults with hypertension over 15 years: findings of nationwide steps of 2007-2021.Journal of diabetes and metabolic disorders · 2024Article
- The effect of trans-theoretical model stage-matched intervention on medication adherence in hypertensive patients.Frontiers in cardiovascular medicine · 2024Article
- Evaluation of Blood Pressure Status and Mortality in Turkey: Findings from Chronic Diseases and Risk Factors Cohort Study.Medicina (Kaunas, Lithuania) · 2023Article
- Prevalence of uncontrolled hypertension and its associated factors in 50-74 years old Iranian adults: a population-based study.BMC cardiovascular disorders · 2023Article
- Article
- Socioeconomic inequalities in metabolic syndrome and its components in a sample of Iranian Kurdish adults.Epidemiology and health · 2023Article
- Article
- Heart diseases, hypertension and effects of antihypertensive medications: Is hypertension a true risk factor of heart diseases?Frontiers in public health · 2022Article
- Trend and predictive modeling of hypertension risk using multiyear community health surveillance data: Evidence from 2019 to 2021.Journal of family & community medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Funding
Abstract
In this cross-sectional population-based study, we used the baseline data of the Prospective Epidemiologic Research Studies in IrAN cohort study collected in Iran from 2014 to 2020. The main outcomes were the prevalence of hypertension and proportion of awareness, treatment, and control based on the 2017 ACC/AHA guideline compared to the seventh report of the Joint National Committee (JNC7). Of the total of 163,770 participants, aged 35-70 years, 55.2% were female. The sex-age standardized prevalence of hypertension was 22.3% (95% CI 20.6, 24.1) based on the JNC7 guideline and 36.5% (31.1, 41.8) based on the ACC/AHA guideline. A total of 24,312 participants [14.1% (10.1, 18.1)] were newly diagnosed based on the ACC/AHA guideline. Compared to adults diagnosed with hypertension based on the JNC7 guideline, the newly diagnosed participants were mainly young literate males who had low levels of risk factors and were free from conventional comorbidities of hypertension. About 30.7% (25.9, 35.4) of them (4.3% of the entire population) were eligible for pharmacologic intervention based on the ACC/AHA guideline. Implementation of the new guideline may impose additional burden on health systems. However, early detection and management of elevated blood pressure may reduce the ultimate burden of hypertension in Iran.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.